This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mindray Medical International CEO Discusses Q1 2012 Results - Earnings Call Transcript

Mindray Medical International (MR)

Q1 2012 Earnings Call

May 08, 2012 08:00 AM ET

Executives

Cathy Gao - Manager of Investor Relations

Jie Liu - COO

David Gibson - President

Alex Lung - CFO



Analysts



Richard Yeh - Citigroup

Shaojing Tong - Bank of America/Merrill Lynch

Jinsong Du - Credit Suisse

Jack Hu - Deutsche Bank

Bin Li - Morgan Stanley

Hao Zhou - Piper Jaffray

Sean Wu - JPMorgan

Jessica Li - CICC

Ingrid Yin - Oppenheimer

Wei Du - Goldman Sachs

Jason Mann - Barclays Capital

Anthony Petrone - Jeffries Group



Presentation



Operator

Good morning everyone, thank you for standing by and welcome to Mindray’s First Quarter 2012 Earnings Conference Call. (Operator Instructions). I would now like to turn the call over to your host for today’s conference, Ms. Cathy Gao, Mindray’s Manager of Investor Relations. Please proceed Ms. Gao.

Cathy Gao

Thank you. Hi, everyone. Welcome to Mindray's 2012 First Quarter Earnings Conference Call. We released our financial results last night and they are now available on the Company's website and Newswire services. There will also be an archived webcast of this conference call on our Investor Relations website.

Joining today's call are Mr. Xu Hang, our Chairman and the Co-CEO; Mr. Li Xiting, our President and the Co-CEO; Mr. Alex Lung, our Chief Financial Officer; Mr. Jie Liu, our Chief Operating Officer; Mr. Minghe Cheng, our Chief Strategic Officer; Mr. David Gibson, our President of North America Operations; and Ms. May Li, our Deputy Chief Financial Officer.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs